Loading clinical trials...
Loading clinical trials...
Which is the Best IVF/ICSI Protocol to be Used in Poor Responders Receiving Growth Hormone as an Adjuvant Treatment ? A Prospective Randomized Study
in this study, we are trying to monitor the effect of the addition of growth hormone on the different down regulation protocols ( long, short, antagonist and microflare). The outcome will be primarily assessed by the clinical pregnancy rates.
Poor responders undergoing IVF/ICSI cycles have emerged as a major problem. the need to find a proper stimulation protocol is a must. in this study we are trying to detect the best stimulation protocol ,in addition to growth hormone ,that can give the highest pregnancy rates in these patients.
Age
20 - 45 years
Sex
FEMALE
Healthy Volunteers
No
private IVF medical center
Giza, Cairo Governorate, Egypt
Start Date
July 1, 2013
Primary Completion Date
January 1, 2015
Completion Date
January 1, 2015
Last Updated
October 20, 2015
287
ACTUAL participants
Growth hormone (Norditropin, Novo nordisk)
DRUG
Lead Sponsor
Woman's Health University Hospital, Egypt
NCT01662466
NCT02179255
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02185326